Quality improvement in neurology: Parkinson disease update quality measurement set

Approximately 630,000 people in the United States carried a diagnosis of Parkinson disease (PD) in 2010, and worldwide estimates indicate that up to 10 million individuals may be diagnosed currently.1,2 The national economic burden of PD was estimated to exceed $14.4 billion in 2010.1 PD is a heterogeneous disorder with motor and nonmotor features that are often underdiagnosed and, in turn, provided limited treatment options. The American Academy of Neurology (AAN) created a quality measurement set in 2010 to provide a framework for measuring progress on addressing these treatment gaps in care.3 The authors thank all the Parkinson's Disease Update Quality Measurement Set Work Group members for their dedication, time, energy, contributions, and work that supported the development of this manuscript: Stewart A. Factor, DO, FAAN (Co-Chair) (American Academy of Neurology); Janis M. Miyasaki, MD, MEd, FRCP, FAAN (Co-Chair) (American Academy of Neurology); Jason Aldred, MD (American Academy of Neurology); Shannon Linder, DNP, FNP-BC, PMHNP (American Academy of Neurology); Abhimanyu Mahajan, MD, MHS (American Academy of Neurology); Sotirios Parashos (American Academy of Neurology); Marie-Hélène Saint-Hilaire, MD, FRCPC, FAAN (American Academy of Neurology); Aleksandar Videnovic, MD, MSc (American Academy of Neurology); Paul Moberg, PhD, ABPP-CN (American Academy of Clinical Neuropsychology); Christina Marciniak, MD (American Academy of Physical Medicine and Rehabilitation); Karen Freshwater, MS, PA-C (American Academy of Physician Assistants); Pearl Jones, MD (American Autonomic Society); William Ondo, MD (American Neurological Association); Patricia A. Totten, MA, OTR, CHT, CLT-UE (American Occupational Therapy Association); Deborah Kegelmeyer, DPT, MS, GCS (American Physical Therapy Association); Dawn Bowers, PhD, ABPP-CN (American Psychological Association); Linda Keilman, DNP, GNP-BC (Gerontological Advanced Practice Nurses Association); Anthony Geraci, MD, MSPH (National Parkinson Foundation); Peter Schmidt, PhD (National Parkinson Foundation); Anna D. Hohler, MD, FAAN (American Academy of Neurology Facilitator); David Wang, DO, FAAN, FAHA (American Academy of Neurology Facilitator); Amy Bennett, JD (American Academy of Neurology Staff); Gina Gjorvad (American Academy of Neurology Staff); Erin Hagen (American Academy of Neurology Staff); Becky Schierman, MPH (American Academy of Neurology Staff).